Novel GlyT1 inhibitor chemotypes by scaffold hopping. Part 1: development of a potent and CNS penetrant [3.1.0]-based lead.
暂无分享,去创建一个
Andrew S. Felts | D. Sheffler | C. Lindsley | P. Conn | C. Niswender | R. Williams | R. Morrison | C. Jones | J. Daniels | Sataya B Jadhav